280 related articles for article (PubMed ID: 35850075)
1. Circulating tumor DNA for breast cancer: Review of active clinical trials.
Baksh M; Mahajan B; Dufresne MM; Shoukry MM; Nussbaum S; Abbaszadeh-Kasbi A; Ashary M; Vandenberg J; Gabriel EM
Cancer Treat Res Commun; 2022; 32():100609. PubMed ID: 35850075
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
3. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
4. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
6. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
Addanki S; Meas S; Sarli VN; Singh B; Lucci A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
[TBL] [Abstract][Full Text] [Related]
7.
Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
[No Abstract] [Full Text] [Related]
8. Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.
Alemzadeh E; Allahqoli L; Dehghan H; Mazidimoradi A; Ghasempour A; Salehiniya H
Oncol Res; 2023; 31(5):667-675. PubMed ID: 37547763
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study.
Tzanikou E; Markou A; Politaki E; Koutsopoulos A; Psyrri A; Mavroudis D; Georgoulias V; Lianidou E
Mol Oncol; 2019 Dec; 13(12):2515-2530. PubMed ID: 31254443
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.
Zavarykina TM; Lomskova PK; Pronina IV; Khokhlova SV; Stenina MB; Sukhikh GT
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069396
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer.
Vlataki K; Antonouli S; Kalyvioti C; Lampri E; Kamina S; Mauri D; Harissis HV; Magklara A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371043
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies: Potential and challenges.
Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
[TBL] [Abstract][Full Text] [Related]
13. [Clinical Application of Liquid Biopsy for Breast Cancer Diagnosis and Treatment].
Shimomura A; Ochiya T
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1197-1202. PubMed ID: 34657047
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Croessmann S; Park BH
Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
[TBL] [Abstract][Full Text] [Related]
15. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
Haupts A; Roth W; Hartmann N
Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.
Förnvik D; Aaltonen KE; Chen Y; George AM; Brueffer C; Rigo R; Loman N; Saal LH; Rydén L
Breast Cancer Res Treat; 2019 Sep; 177(2):447-455. PubMed ID: 31236809
[TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.
Rossi G; Mu Z; Rademaker AW; Austin LK; Strickland KS; Costa RLB; Nagy RJ; Zagonel V; Taxter TJ; Behdad A; Wehbe FH; Platanias LC; Gradishar WJ; Cristofanilli M
Clin Cancer Res; 2018 Feb; 24(3):560-568. PubMed ID: 29180605
[No Abstract] [Full Text] [Related]
18. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
19. Application of circulating tumor DNA in breast cancer.
Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA.
Banys-Paluchowski M; Fehm TN; Grimm-Glang D; Rody A; Krawczyk N
Oncol Res Treat; 2022; 45(1-2):4-11. PubMed ID: 34718243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]